“The Study (Tuberculosis Working to Empower Nations’ Diagnostic Efforts (TWENDE)) is granted approval for implementation”, wrote the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU) in a letter to the TWENDE Consortium dated 15th August 2016 and signed by Mr. Ambrose Rachier, SERU Chairman.
This means, therefore, that SERU has approved to be conducted in Kenya the East Africa wide TWENDE research study. The Principal Investigator for TWENDE in Kenya is Dr. Evans Inyagala Amukoye. Ms. Norah Owaraga is the TWENDE Social Scientist and she will support the TWENDE Kenya Team as an advisor for the qualitative data collection, processing and analysis. Dr. Wilber Sabiiti is the TWENDE Team Leader.
Hon. Milly Molly Among, Vice Chairperson of Oyam District Local Government made these remarks during an Oyam District Development Partners’ Workshop that was held on Monday, 19th September 2016 in Oyam. She was representing the Oyam DLG Chairman, Hon. Nelson Adea Akar.
“I want to thank CPAR Uganda Ltd. They have been with us for a long time. And am happy to hear that they are coming back, because what they did in the past I think they are going to continue from where they left off and do better than what they did before. So, CPAR Uganda Ltd you are welcome in Oyam.”
Let me take this opportunity to sincerely thank the Almighty God for having brought all of us to Oyam District. Oyam has been one of the most affected districts due to insecurity but at the moment we are in peace.
The Makerere University Kampala (MUK) School of Biomedical Sciences Higher Degree Research and Ethics Committee (SBS-HDREC) has approved to be conducted in Uganda the East Africa wide research study titled: “Tuberculosis Working to Empower Nations’ Diagnostic Efforts (TWENDE)”
In a letter signed by Dr. Erisa Mwaka, Chairperson, SBS-HDREC and that is dated 9th September 2016 the SBS-HDREC informed the TWENDE Consortium as follows: “In the matter concerning the review of a research proposal entitled: “Tuberculosis Working to Empower Nations’ Diagnostic Efforts” the Investigator has met all the requirements as stated by SBS-HDREC and therefore, the protocol is APPROVED.”
Since January 2016, CPAR is implementing a research on Tuberculosis (TB) code-named: “Tuberculosis:...More detail
In 2016, CPAR began its Policy Advocacy Programmes in which it functions as a Consulting Organisation....More detail